Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors.

MLA

Suciu, Ilinca, et al. “Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors.” Antioxidants (Basel, Switzerland), vol. 13, no. 1, Dec. 2023. EBSCOhost, https://doi.org/10.3390/antiox13010049.

APA

Suciu, I., Delp, J., Gutbier, S., Suess, J., Henschke, L., Celardo, I., Mayer, T. U., Amelio, I., & Leist, M. (2023). Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. Antioxidants (Basel, Switzerland), 13(1). https://doi.org/10.3390/antiox13010049

Chicago

Suciu, Ilinca, Johannes Delp, Simon Gutbier, Julian Suess, Lars Henschke, Ivana Celardo, Thomas U Mayer, Ivano Amelio, and Marcel Leist. 2023. “Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors.” Antioxidants (Basel, Switzerland) 13 (1). doi:10.3390/antiox13010049.